Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

Susan Bernstein  |  Issue: February 2016  |  February 16, 2016

Hypoxia is quite pronounced in psoriatic arthritis compared with RA. Angiogenesis is dysregulated in inflamed joints. “These blood vessels are not delivering enough oxygen to cells to overcome that hypoxic situation,” said Dr. Veale. Hypoxia not only induces angiogenesis but also pro-inflammatory mediators, and the invasion and migration of fibroblasts. This process is Notch dependent. “If we knock down the Notch, we can inhibit hypoxia-induced inflammatory mechanisms,” he said.

Many transcriptive factors are involved in cellular and other changes that occur due to hypoxia, including hypoxia-inducible-factor 1-alpha (HIF-1α), which is significantly upregulated due to a lack of oxygen. Prolyl hydroxylase domain proteins, including PHD2, which is prominent in RA, are an important area of research. When PHD2 is knocked down in RA, you see greater activation of HIF-1α, said Dr. Veale.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Interventions, such as TNF inhibitors, can reduce blood flow and metabolic activity in inflamed joints, including affecting oxygen levels, he said.2 These drugs alter cellular bioenergetics, and GLUT1, that key marker of metabolic activity in joints, goes down.

Energy Consumption

Inflammation uses up a lot of energy, said Stephen Young, PhD, FHEA, Reader in Rheumatology at the Institute of Inflammation and Ageing at the University of Birmingham in the U.K. “What’s using this energy?” Lymphocytes, resting T cells, and activated T cells are possible culprits. In sepsis or in high levels of trauma, you also see high energy levels. During sepsis, protein and energy metabolism are accelerated, and leucine and glucose levels go up, too. “Individual metabolites influence or vary in chronic disease.” For example, glutathione, a major antioxidant, is depressed in RA patients’ serum.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Metabolism leaves behind important clues to understand the inflammatory process. “Genomics and proteomics tell you what might happen, but metabolomics tell you what is happening or what did happen,” said Dr. Young. After an initial trauma, metabolomic analysis of blood serum shows a distinct, inflammation-related trajectory in metabolites following that injury, he said. In early arthritis patients, metabolites correlate with C-reactive protein levels in the blood, and these changes are linked to the inflammatory response. Creatinine is one possible important biomarker of this metabolic process.

After some acute damage to tissue, catabolic processes dominate, and then anabolism kicks in for tissue repair, followed by recovery. With the acute inflammation you see after a trauma or burn, there are both on and off processes, Dr. Young said. After a severe burn, for example, there are high levels of specific metabolites, and “there is some evidence for glycolysis and lipolysis in burn patients.” These may be markers of immune cell involvement or hypoxic metabolism in the damaged tissues, he said.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)inflammationinflammatorymetabolicpathwaysResearchRheumatic Diseaserheumatologysignaling

Related Articles

    Harder to Breathe: The Infrastructure Behind Medical Oxygen

    January 10, 2022

    Last year, in Texas, they had no room to breathe. Texas has 301 designated trauma centers equipped to provide intensive care, 200 of which can care for at least four critically ill patients. In August 2021, 75 of these hospitals reported having no available beds in their intensive care units. Zero. This was due, in…

    AJPhoto / Science Source

    Tips for Diagnosing Metabolic Myopathies

    September 17, 2019

    When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

    Researchers Find the Switch that Underlies Macrophage Metabolism

    March 28, 2016

    During pro-inflammatory stimulation, a recent study found HIF1α—not Myc—is required for the regulation of glycolysis in macrophages. Researchers examined macrophages and the distinct transcriptional programs engaged in response to mitogenic and pro-inflammatory stimulation…

    Diagnosis: Myopathy

    July 1, 2009

    Presentation and evaluation of metabolic causes

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences